Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL review.
Ditzinger F, Price DJ, Ilie AR, Köhl NJ, Jankovic S, Tsakiridou G, Aleandri S, Kalantzi L, Holm R, Nair A, Saal C, Griffin B, Kuentz M.
Ditzinger F, et al. Among authors: kalantzi l.
J Pharm Pharmacol. 2019 Apr;71(4):464-482. doi: 10.1111/jphp.12984. Epub 2018 Aug 2.
J Pharm Pharmacol. 2019.
PMID: 30070363
Review.